Preclinical evaluation of CRS3123 for the treatment of helicobacter pylori infections

Ended Project Grant Awarded Last action

Award ID
R43AI149820
Recipient
Awarding agency
Obligated
$143,893

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Funding
  • $143,915.00 Federal
  • -$22.50 Non-federal
Place of performance
Boulder, CO 80301, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$23 $0
Amendment -$23 -$23
Original award $143,960 $0

Quick answers

Who received award R43AI149820?

R43AI149820 was awarded to Crestone, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 15, 2020.

How much is award R43AI149820 worth?

$143,893 has been obligated on R43AI149820: $143,915 in federal funding and -$23 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award